Mumps and ovarian cancer: Modern interpretation of an historic association

Cancer Causes and Control

Volumn 21, Issue 8, 2010, Pages 1193-1201

  Cramer, Daniel W ^a   Vitonis, Allison F ^a   Pinheiro, Simone P ^b   McKolanis, John R ^c   Fichorova, Raina N ^a   Brown, Kevin E ^d   Hatchette, Todd F ^e,f   Finn, Olivera J ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

CA125; MUC1; Mumps parotitis; Ovarian cancer

Indexed keywords

CA 125 ANTIGEN; MUCIN 1; MEMBRANE PROTEIN; MUC1 PROTEIN, HUMAN; MUC16 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE; ANTIBODY DETECTION; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; BLOOD ANALYSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; MALE; MUMPS; OVARY CANCER; PAROTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNITY; BLOOD; CASE CONTROL STUDY; CHILD; IMMUNOLOGY; MIDDLE AGED; OVARIAN NEOPLASMS; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CA-125 ANTIGEN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUCIN-1; MUMPS; OVARIAN NEOPLASMS; YOUNG ADULT;

EID: 77955712706     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9546-1     Document Type: Article

References (26)

1. RO West 1966 Epidemiology study of malignancies of the ovaries Cancer 19 1001 1007 10.1002/1097-0142(196607)19:7<1001::AID-CNCR2820190714>3.0.CO;2- S 1:STN:280:DyaF287ltlWqtg%3D%3D 5939299
2. EL Wynder H Dodo HR Barber 1969 Epidemiology of cancer of the ovary Cancer 23 2 352 370 10.1002/1097-0142(196902)23:2<352::AID- CNCR2820230212>3.0.CO;2-4 1:STN:280:DyaF1M7htFejtQ%3D%3D 5764976
3. ML Newhouse RM Pearson JM Fullerton EA Boesen HS Shannon 1977 A case control study of carcinoma of the ovary Br J Prev Soc Med 31 3 148 153 1:STN:280:DyaE1c%2FmtFChsQ%3D%3D 588853
4. J Menczer M Modan L Ranon A Golan 1979 Possible role of mumps virus in the etiology of ovarian cancer Cancer 43 4 1375 1379 10.1002/1097-0142(197904) 43:4<1375::AID-CNCR2820430427>3.0.CO;2-D 1:STN:280:DyaE1M7ovFaltw%3D%3D 445337
5. A Golan AC Joosting ME Orchard 1979 Mumps virus and ovarian cancer S Afr Med J 56 1 18 20 1:STN:280:DyaL3c%2FhsVylsw%3D%3D 483098
6. DW Cramer WR Welch S Cassells RE Scully 1983 Mumps, menarche, menopause, and ovarian cancer Am J Obstet Gynecol 147 1 1 6 1:STN:280:DyaL3szgsF2hsw%3D%3D 6614075
7. MH Schiffman P Hartge LP Lesher L McGowan 1985 Mumps and postmenopausal ovarian cancer Am J Obstet Gynecol 152 1 116 118 1:STN:280:DyaL2M7ps1ejtA%3D%3D 3993709
8. Y Chen PC Wu JH Lang, et al. 1992 Risk factors for epithelial ovarian cancer in Beijing, China Int J Epidemiol 21 1 23 29 10.1093/ije/21.1.23 1:CAS:528:DyaK3sXitlOjsr8%3D 1544753
9. MA Merritt AC Green CM Nagle PM Webb 2008 Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer Int J Cancer 122 1 170 176 10.1002/ijc.23017 1:CAS:528:DC%2BD2sXhsVSgtbvJ 17721999
10. DW Cramer L Titus-Ernstoff JR McKolanis, et al. 2005 Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer Cancer Epidemiol Biomarkers Prev 14 5 1125 1131 10.1158/1055-9965.EPI-05-0035 1:CAS:528:DC%2BD2MXktFCksb8%3D 15894662
11. Y Hamanaka Y Suehiro M Fukui, et al. 2003 Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer Int J Cancer 103 1 97 100 10.1002/ijc.10801 1:CAS:528:DC%2BD38Xptl2htrk%3D 12455059
12. L Alos B Lujan M Castillo, et al. 2005 Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands Am J Surg Pathol 29 6 806 813 10.1097/01.pas.0000155856.84553.c9 15897748
13. RN Fichorova N Richardson-Harman M Alfano, et al. 2008 Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study Anal Chem 80 12 4741 4751 10.1021/ac702628q 1:CAS:528:DC%2BD1cXlvFOhu7Y%3D 18484740
14. Egger M, Smith G, Altman D (2001) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ Publishing Group, London
15. SE Baldus K Engelmann FG Hanisch 2004 MUC1 and the MUCs: a family of human mucins with impact in cancer biology Crit Rev Clin Lab Sci 41 2 189 231 10.1080/10408360490452040 1:CAS:528:DC%2BD2cXlslalt70%3D 15270554
16. AM Vlad OJ Finn 2004 Glycoprotein tumor antigens for immunotherapy of breast cancer Breast Dis 20 73 79 1:CAS:528:DC%2BD2cXhtVahsLvL 15687709
17. BJ Campbell LG Yu JM Rhodes 2001 Altered glycosylation in inflammatory bowel disease: a possible role in cancer development Glycoconj J 18 11-12 851 858 10.1023/A:1022240107040 1:CAS:528:DC%2BD3sXotVyktA%3D%3D 12820718
18. KR Jerome AD Kirk G Pecher WW Ferguson OJ Finn 1997 A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis Cancer Immunol Immunother 43 6 355 360 10.1007/s002620050344 1:STN:280:DyaK2s3itVSgsA%3D%3D 9067407
19. M Nakajima T Manabe Y Niki T Matsushima 1998 Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis Thorax 53 9 809 811 10.1136/thx.53.9.809 1:STN:280:DyaK1M3lt1Khtw%3D%3D 10319067
20. H Takaishi S Ohara K Hotta, et al. 2000 Circulating autoantibodies against purified colonic mucin in ulcerative colitis J Gastroenterol 35 1 20 27 10.1007/PL00009971 1:STN:280:DC%2BD3c%2Fps1eqtQ%3D%3D 10632536
21. N Kohno 1999 Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis J Med Invest 46 151 158 1:STN:280: DC%2BD3c7ltF2htw%3D%3D 10687309
22. AM Vlad S Muller M Cudic, et al. 2002 Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells J Exp Med 196 11 1435 1446 10.1084/jem.20020493 1:CAS:528:DC%2BD38XpsVahtL8%3D 12461079
23. K Okamura T Kiyoshima K Shima, et al. 2002 Immunohistochemical expression of CA19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland Oral Oncol 38 3 244 250 10.1016/S1368-8375(01)00049-5 1:CAS:528:DC%2BD38XjtVehurg%3D 11978546
24. PJ Mink ME Sherman SS Devesa 2002 Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998 Cancer 95 11 2380 2389 10.1002/cncr.10935 12436446
25. Tipples G, Beirnes J, Hiebert J et al (2008) Laboratory guidelines for the diagnosis of mumps v.3 (3 April 2008), http://www.nml-lnm.gc.ca/guide/docs/ Mumps-Lab-guide.pdf. Accessed 14 July 2009
26. L Jin S Beard DW Brown 1999 Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes J Infect Dis 180 3 829 833 10.1086/314957 1:STN:280:DyaK1MzmslGqsw%3D%3D 10438373